Major trial tests new weekly shot to fight obesity

NCT ID NCT07311850

Recruiting now Disease control Sponsor: Metsera, a wholly owned subsidiary of Pfizer Source: ClinicalTrials.gov ↗

Summary

This study is testing a new weekly injection called MET097 to see how well it helps people with obesity or overweight lose weight and improve related health measures. It will involve about 3,500 adults who have weight-related health issues like high blood pressure or sleep apnea, but not diabetes. The main goal is to see how much body weight changes after about 64 weeks of treatment, while also checking the drug's safety.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY AND OVERWEIGHT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site 97301-001007
RECRUITING

Riverside, California, 92506, United States
Research Site 97301-001070
RECRUITING

Torrance, California, 90504, United States
Research Site 97301-001077
RECRUITING

Englewood, Colorado, 80113, United States
Research Site 97301-001309
RECRUITING

Cary, North Carolina, 27511, United States
Research Site 97302-001001
RECRUITING

Hollywood, Florida, 33024, United States

Conditions

Explore the condition pages connected to this study.

OBESITY AND OVERWEIGHT